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Abstract We characterized the promoter activity of a medaka
¢sh intestinal guanylyl cyclase gene, OlGC6, by assay of en-
zyme activity in response to various promoter^luciferase fusion
gene constructs introduced into CACO-2 cells and medaka ¢sh
embryos. A transient transfection assay of the various fusion
gene constructs showed that the nucleotides between 398 and
389 in the 5P-£anking region of the OlGC6 gene are essential
for transcription of the OlGC6 gene in CACO-2, and that the
OlGC6 gene fragment between 398 and +50 is su⁄cient to
drive gene expression in the medaka ¢sh intestine. An electro-
phoretic mobility shift assay and ultraviolet (UV) cross-linking
experiments demonstrated that a nuclear protein from CACO-2
cells and the adult medaka ¢sh intestinal cells binds speci¢cally
to the AGACCTTTGC nucleotides in the regulatory element.
0 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
Key words: Guanylyl cyclase; Intestine; Medaka ¢sh;
cis-Regulatory element; CACO-2 cell
1. Introduction
The intestine of vertebrates expresses a speci¢c gene for
membrane guanylyl cyclase (membrane GC). In mammals,
such a membrane GC gene, GC-C, is expressed at high levels
throughout the epithelium of the intestine, from the duode-
num to the colon, and the gene products are detected abun-
dantly in both the crypts and villi of the small intestine, as
well as in the crypts and surface epithelium of the colon [1^3].
Mammalian GC-C has been shown to be the receptor for
Escherichia coli heat-stable enterotoxin (STa) [4], and for the
endogenous peptides guanylin and uroguanylin [5,6]. In re-
sponse to the binding of the ligand to the extracellular domain
of GC-C, the intracellular cyclase catalytic domain converts
GTP to cGMP, subsequently activating cGMP-dependent
protein kinase II (PKG-II). It has been reported that PKG-
II phosphorylates the cystic ¢brosis transmembrane conduc-
tance regulator, increases chloride secretion, and inhibits elec-
troneutral sodium absorption in the gastrointestinal tract [7].
The pathological consequence in the case of STa is severe
secretory diarrhea [8]. Targeted disruption of the GC-C gene
induces no deleterious e¡ects in mice and, in fact, confers
resistance to STa-induced diarrhea [9,10]. However, all verte-
brates contain an intestine-speci¢c membrane GC gene, imply-
ing that it serves some important and unde¢ned physiological
roles.
In a previous study, we isolated a cDNA clone for a mem-
brane GC, OlGC6, from a medaka ¢sh intestine cDNA li-
brary, and determined the complete nucleotide sequences of
the cDNA and genomic DNA [11]. The 5P-£anking region of
the OlGC6 gene was found to be not well-conserved with that
of the mammalian GC-C gene, the intestinal expression of
which requires hepatocyte nuclear factor 4K (HNF-4K) or
Cdx2 [12^14]. This ¢nding suggests that the transcriptional
regulatory mechanisms of the OlGC6 and GC-C genes di¡er.
In this paper, we report that the nucleotides between 398 and
389 in the 5P-£anking regions are important to transcription
of the OlGC6 gene in CACO-2 cells, and that the OlGC6 gene
fragment between 398 and +50 is su⁄cient to drive intestinal
gene expression in the adult medaka ¢sh. We also report that
a speci¢c nuclear protein from CACO-2 cells or from the
medaka ¢sh intestines binds to the AGACCTTTGC nucleo-
tides in the regulatory element.
2. Materials and methods
2.1. Southern blot hybridization
A genomic Southern hybridization experiment was carried out us-
ing genomic DNA from a male individual of Oryzias latipes strain
Hd-rR and a OlGC6 cDNA fragment (nucleotides +184 to +225).
Extraction of genomic DNA, blotting, labeling of the probe, and hy-
bridization were performed as described previously [15]. Blots were
washed three times with 2USSC, 0.1% sodium dodecyl sulfate (SDS),
at 50‡C for 15^20 min. Imaging of the radioactive signals was per-
formed using a FUJIX Bio-Imaging Analyzer BAS2000 (Fuji Photo
Film, Japan).
2.2. Primer extension analysis
Total RNA was prepared from the intestines of the adult medaka
¢shes (orange-red variety of O. latipes) by the acid guanidium thio-
cyanate/phenol/chloroform extraction method [16]. Poly(A)þ RNA
was isolated using Oligotex-dT30GSuperf (Roche Molecular Biochem-
icals, Switzerland), according to the manufacturer’s protocol. A prim-
er extension experiment with 5 Wg of poly(A)þ RNA was carried out
essentially by means of a previously described procedure [15].
2.3. Construction of the fusion genes
Genomic DNA fragments (nucleotides 31757 to +50, 31001 to
+50, 3491 to +50, 3299 to +50, 3201 to +50, 398 to +50, 388 to
+50, 347 to +50, 318 to +50) were ampli¢ed using polymerase chain
reaction (PCR). The PCR was conducted in a 50-Wl reaction mixture
containing 100 pg of template plasmid clone [11] (the 5P-£anking
region of the OlGC6 gene), 1UEx Taq bu¡er, 0.2 mM dNTP mixture,
10 pmol paired primers, and 2.5 units Ex Taq (TaKaRa, Japan). The
reaction was performed under the following conditions: 1 min at 94‡C
and 30 cycles of 30 s at 96‡C, 30 s at 60‡C, and 3 min at 72‡C. The
downstream primer used was 5P-TCAGAAAGCTTCTCCCTTT-
GTGCTCTGC-3P and the upstream primers were 5P-AAGGGGGT-
ACCATCTTCATACGGCGTC-3P, 5P-CTGGAGGGTACCCCCCC-
TCAG-3P, 5P-GGCCACGGTACCTTTCTCTCCTGG-3P, 5P-TGTG-
AGGGTACCCTGCTGTTCAG-3P, 5P-CCACATGGTACCTGAAG-
CTCTTATC-3P, 5P-GCAGCCGGTACCGCACACACG-3P, 5P-ACA-
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GCCGGTACCTGTGTCTTTAAAGG-3P, and 5P-ATTGGTACCC-
TGACAAGGAAAGGACAACTC-3P (GenBank1 accession number
AB007192). For preparation of the mutant construct, the ¢rst PCR
was performed as described by Ho et al. [17] using two sets of prim-
ers: 5P-AAGGGGGTACCATCTTCATACGGCGTC-3P, 5P-GTGC-
AAAGGTAGTTGTGTGCGCTG-3P for the upstream fragment; 5P-
GCACACAACTACCTTTGCACACCC-3P, 5P-TCAGAAAGCTTC-
TCCCTTTGTGCTCTGC-3P for the downstream fragment. The sec-
ond PCR was performed employing the ¢rst PCR fragment as a
template using the following primers: 5P-AAGGGGGTACCATCTT-
CATACGGCGTC-3P and 5P-TCAGAAAGCTTCTCCCTTTGTGC-
TCTGC-3P. The PCR product was digested with HindIII and KpnI
and ligated into the HindIII^KpnI sites in a pGL3-enhancer luciferase
vector (Promega, Madison, WI, USA). Plasmid was puri¢ed using the
Qiagen Lambda Midi Kit (Qiagen, Germany). The correctness of the
nucleotide sequence of each plasmid construct was examined by re-
striction enzyme digestion and partial sequencing.
2.4. Cell culture and DNA transfections
CACO-2 cells and COS1 cells were cultured in Dulbecco’s modi¢ed
Eagle’s medium (DMEM) supplemented with 10% heat-inactivated
fetal bovine serum (FBS) (HyClone0, Logan, UT, USA) and 1Upen-
icillin^streptomycin^glutamine (Gibco1 Invitrogen Corporation,
Netherlands) under a humidi¢ed 5% CO2 atmosphere. For the report-
er enzyme assay, 106 CACO-2 cells were plated per well in a six-well
plate, or 106 COS1 cells were plated in a 100U20 mm dish and
cultured for 24 h before transfection. A plasmid construct consisting
of the OlGC6 promoter region and luciferase gene was cotransfected
with pSV-L-galactosidase (20 Wg) (Promega) into CACO-2 cells or
COS1 cells by the calcium phosphate coprecipitation method. After
a 48-h culture of CACO-2 cells or a 24-h culture of COS1 cells, cells
were lysed in Reporter Lysis Bu¡er (Promega), and the luciferase
activity was assayed using a Luciferase Assay System (Promega) ac-
cording to the manufacturer’s protocol. L-Galactosidase activity was
also assayed in order to normalize it in regard to variations in trans-
fection e⁄ciency.
2.5. Production and identi¢cation of transgenic medaka ¢sh
The plasmid constructs 2kbpGC6-Luc, 100bpGC6-Luc, 50bpGC6-
Luc, and 20bpGC6-Luc containing 31757 to +50, 398 to +50, 347
to +50, and 318 to +50 of the OlGC6 gene fragments, respectively,
upstream of the luciferase gene (see Section 2.3) were microinjected
into a fertilized medaka ¢sh embryo as described previously [18] and
allowed to develop to term. Fishes were kept in indoor tanks under
arti¢cial reproductive conditions (10 h dark, 14 h light, 27‡C) and fed
on OtohimeB2 £akes (Nisshinseihun/Nisshinshiryou, Japan). A med-
aka ¢sh carrying a transgene was identi¢ed for the presence of the
luciferase gene by PCR of genomic DNA from the caudal ¢n using
the following speci¢c primers (GenBank1 accession number U47295):
the upstream primer 5P-GCTGGAGAGCAACTGCATAA-3P and the
downstream primer 5P-CCTTCTTGGCCTTTATGAGG-3P. A F0
medaka ¢sh possessing a transgene was mated with a non-transgenic
littermate to establish a line from each founder. O¡spring was ana-
lyzed by both PCR and Southern blot hybridization for transmission
of the transgene.
2.6. RNA analysis by reverse transcription (RT)-PCR
Total RNA was prepared from 20 medaka ¢sh embryos (stages 35^
39) and several adult medaka ¢sh tissues by the acid guanidium thi-
ocyanate/phenol/chloroform extraction method [16]. The ¢rst-strand
cDNA was synthesized from total RNA of embryos (2.0 Wg) or total
RNA of each tissue (500 ng) using Super Script1 First-Strand Syn-
thesis System (Invitrogen1 Life Technologies) according to the pro-
tocol of the manufacturer. PCRs were then carried out with speci¢c
primers for the luciferase gene (GenBank1 accession number
U47295), the OlGC6 gene (GenBank1 accession number
AB007192), or the OlCA1 gene (the cytoplasmic actin gene of the
medaka ¢sh, GenBank1 accession number D89627): luc-F, 5P-GCT-
GGAGAGCAACTGCATAA-3P and luc-R, 5P-CCTTCTTGGCCTT-
TATGAGG-3P (1570-bp product); OlGC6-F, 5P-ACACTGATCCA-
GAGCTGACA-3P, and OlGC6-R, 5P-CCTTCTTCAGCATTGATA-
GC-3P (226-bp product); OlCA1-F, 5P-GGGTCTTCA-TGACGGGC-
3P, and OlCA1-R, 5P-CAAGTCGGAACACATGTGCA-3P (100-bp
product) and 2 Wl of the reverse-transcribed cDNA solution. The
ampli¢cation conditions were as follows: 96‡C, 30 s; 56‡C, 30 s;
and 72‡C, 2.5 min performed 35 cycles. PCR products were analyzed
by electrophoresis on a 1.5% agarose gel for the OlGC6 gene, the
OlCA1 gene and on a 0.7% agarose gel for the luciferase gene.
2.7. In situ hybridization
A digoxigenin (DIG)-labeled probe was prepared by transcription
from pBluescript II (KS+) containing the OlGC6 cDNA fragment
(nucleotides +1 to +314) at NotI and XhoI sites, and the luciferase
gene (from pGL3 vector) at HindIII and XbaI sites using a DIG-RNA
Labeling kit (Roche Molecular Biochemicals) according to the man-
ufacturer’s instructions.
The frozen tissue was sliced into a 10-Wm section on a cryostat
microtome (Leica, CM1900). The section was mounted on a slide
coated with silane and dried. The section was ¢xed with 4% parafor-
maldehyde in phosphate-bu¡ered saline (PBS) and washed with PBS
twice, then incubated in a solution containing 10 Wg/ml proteinase K
(Roche Molecular Biochemicals) for 4 min at room temperature.
After washing twice with PBS for 5 min, the section was acetylated
with 0.25% acetic anhydride in 1.5% triethanolamine for 10 min at
room temperature. After washing with PBS for 5 min, the section was
dehydrated through ethanol serial washes and then dried.
The section was prehybridized in a solution consisting of 50% form-
amide, 600 mM NaCl, 1UDenhardt’s solution, 0.25% SDS, 1 mM
ethylenediamine tetraacetic acid (EDTA), 10% dextran sulfate, 200
Wg/ml yeast tRNA, and 10 mM Tris^HCl, pH 7.6 at 55‡C for 1 h.
After prehybridization, the section was transferred to fresh hybridiza-
tion bu¡er containing 40 ng/ml DIG-labeled RNA probe. Hybridiza-
tion was continued for at least 16 h at 55‡C. The hybridized section
was rinsed in 5USSC at 55‡C and then washed in a solution contain-
ing 5USSC and 50% formamide at 55‡C. The section was then treated
with a solution containing 1 mM EDTA, 0.5 M NaCl, and 10 mM
Tris^HCl, pH 7.5 with RNase A (Roche Molecular Biochemicals) for
30 min at 37‡C, followed by washing in 2USSC at 55‡C for 20 min
and in 0.2USSC at 55‡C for 20 min. After this step, the section was
washed for 5 min at room temperature with DIG 1 bu¡er (150 mM
NaCl and 100 mM Tris^HCl, pH 7.5) and then incubated in 0.5%
bovine serum albumin (BSA) and 0.1% Tween 20 in DIG 1 bu¡er for
1 h at room temperature, followed by incubation in 1:1000 diluted
anti-digoxigenin Fab fragment conjugated with alkaline phosphatase
(DIG Nucleic Acid Detection kit), in DIG 1 bu¡er containing 0.1%
Tween 20 for 1 h at room temperature. Unbound antibody conjugate
was removed by washing twice with DIG 1 bu¡er containing 0.1%
Tween 20 for 15 min each. Finally, the section was preincubated in
DIG 3 bu¡er (100 mM NaCl, 50 mM MgCl2, and 100 mM Tris^HCl,
pH 9.5) and then incubated for 3 days in the dark in the same bu¡er
containing the substrates, nitroblue tetrazolium (NBT, 450 Wg/ml),
and 5-bromo-4-chloro-3 indolyl phosphate (BCIP, 175 Wg/ml) (Roche
Molecular Biochemicals). Color development was stopped by incuba-
tion in DIG 3 bu¡er.
2.8. Preparation of nuclear protein extract
Preparation of nuclear extract from CACO-2 cells (3U108) was
carried out exactly according to the protocol described by Dignam
et al. [19]. That from the adult medaka ¢sh intestines or other tissues
was carried out according to the method described by Bres and Eales
[20]. Protein concentration was determined by the method of Lowry et
al., according to Schacterle and Pollack’s modi¢cation [21,22].
2.9. Electromobility shift assay (EMSA)
Oligonucleotides corresponding to a part of the OlGC6 promoter
(nucleotides 3299 to 3201) were ampli¢ed by PCR, with PCR prod-
ucts being ¢lled in the 5P-adenosine protruding end by Klenow (Ta-
KaRa) and [K-32P]dTTP (Amersham Pharmacia Biotech, Piscataway,
NJ, USA). The labeled probe was puri¢ed using a CHROMA
SPIN+STE-30 column (Clontech, Palo Alto, CA, USA). Oligonucleo-
tides corresponding to a part of the OlGC6 promoter in both orien-
tations (nucleotides 3108 to 379, wild type, designated as E1, or
mutations; see Fig. 5A) were synthesized so as to leave a 5P-guanine
protruding upon annealing. The annealed double-stranded oligonu-
cleotide was ¢lled in at the protruding 5P-end by Klenow (TaKaRa)
and [K-32P]dCTP (Amersham Pharmacia Biotech). The labeled probe
was puri¢ed by a CHROMA SPIN+STE-10 column (Clontech). A
protein^DNA binding reaction was performed in a bu¡er containing
4% glycerol, 50 mM NaCl, 2.5 mM MgCl2, 5 mM dithiothreitol
(DTT), 1 Wg of poly(dI-dC)^poly(dI-dC) (Amersham Pharmacia Bio-
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tech), 10 mM Tris^HCl (pH 7.5), and the labeled probe. The reaction
was initiated by the addition of nuclear extract and was incubated for
30 min at room temperature in order to proceed with the formation of
protein^DNA complex. The reaction mixture was then subjected to
electrophoresis with a 4% polyacrylamide gel in 0.5UTBE running
bu¡er (1 mM EDTA and 45 mM Tris^borate, pH 8.3). The gel was
dried before visualization of the radiolabeled complex by autoradiog-
raphy. For the competition assays, unlabeled competitor was added to
the reaction mixture before addition of the nuclear extract.
2.10. UV cross-linking analysis
A protein^DNA binding reaction was performed in a 1.5-ml tube
under the same conditions as those used for the EMSA. Mineral oil
was added to the tube to prevent evaporation, and the reaction mix-
ture was then irradiated for 60 min on ice using an ultraviolet lamp
with a 254-nm emission. The cross-linked proteins were separated by
electrophoresis on a denaturing 12% polyacrylamide gel. The gel was
dried and visualized for the radiolabeled complex by autoradiography.
2.11. Database search
Transcription factor binding sequences within the regulatory ele-
ment were searched using the TFSEARCH program from Genome-
Net (http://www.rwcp.or.jp/papia/) [23].
3. Results
3.1. Southern hybridization
A Southern blot hybridization experiment demonstrated
that only a single band was detected in each lane, suggesting
that only a single copy of the OlGC6 gene is present on the
medaka ¢sh genome (data not shown).
3.2. Characterization of the OlGC6 gene promoter in
cultured cell
The transcription initiation site of the OlGC6 gene, deter-
mined by the primer extension analysis, was 213 bp upstream
of the putative start codon and was designated as +1 (data
not shown). A putative TATA box exists in the position be-
tween 330 and 323 and there are several consensus binding
sequences for the Cdx2 homeobox protein and GATA family
proteins, which are known to be important for intestine-spe-
ci¢c gene expression [24,25].
To understand the mechanisms of transcription of the
OlGC6 gene, we analyzed the promoter/enhancer activity of
the gene by assaying the luciferase activity of the various lu-
ciferase fusion gene constructs and introduced the fusion gene
constructs into CACO-2 cells (intestine-derived cell line) or
COS1 cells (kidney-derived cell line). With CACO-2 cells,
the luciferase activity did not change until deletion down
past 3299 (Fig. 1). Further deletion down to 318 (deletion
of the TATA box) resulted in almost no luciferase activity
(Fig. 1). The luciferase activity of a 3201/+50 construct was
approximately half that of the constructs 3299/+50, 3491/
+50, 31001/+50, and 31757/+50 (Fig. 1). The luciferase ac-
tivity of 388/+50 and 347/+50 constructs was approximately
half that of the constructs 3201/+50 and 398/+50, respec-
tively (Fig. 1). Introduction of the 3-bp mutation into the
region at 391, 390, and 389 in the construct 31757mut-
CAG/+50 reduced the luciferase activity down to the same
level as that of a 347/+50 construct. These results suggest
that there are three important regions (the ¢rst, between
3299 and 3201; the second, between 398 and 388; the
third, between 347 and 318) for OlGC6 gene transcription.
On the other hand, although the luciferase activity was mea-
surable with COS1 cells, it remained much lower than that
seen with CACO-2 cells (data not shown). When deleted down
to 3201, the luciferase activity was almost the same level as
that of the empty construct, suggesting that the nucleotides
between 398 and 389 are essential to transcription of the
OlGC6 gene only in CACO-2 cells.
3.3. Characterization of the OlGC6 gene promoter in
medaka ¢sh
To further understand the regulatory mechanisms of the
OlGC6 transcription in vivo, we generate transgenic medaka
¢sh by microinjecting the fusion gene constructs into the med-
aka ¢sh embryos. Three transgenic founders were generated
for 2kbpGC6-Luc, six founders for 100bpGC6-Luc, four
founders for 50bpGC6-Luc, and three founders for
20bpGC6-Luc. Each founder was mated with non-transgenic
littermates to establish a line, and the embryos of each F1
were analyzed to examine the transmission of the transgene.
As a result, one line was obtained for 2kbpGC6-Luc, three
lines for 100bpGC6-Luc, four lines for 50bpGC6-Luc, and
two lines for 20bpGC6-Luc. Two of four lines for
50bpGC6-Luc were lost, because F1 individuals died before
the beginning of the experiments. Transgene expression was
detected by RT-PCR analysis. In our previous study using
RT-PCR analysis, we demonstrated that the OlGC6 gene is
expressed in the embryo and in the adult medaka ¢sh, mainly
in the intestine and to a much lesser extent in the brain, eye,
kidney, liver, spleen, and gonad, but not in the gill and heart
[11]. In the embryos (stages 35^39), the lines carrying
2kbpGC6-Luc (line 11), and 100bpGC6-Luc (lines 10, 12,
and 14) all expressed the luciferase gene. In contrast, the lines
with 50bpGC6-Luc (lines 7 and 9) or 20bpGC6-Luc (lines 1
and 2) did not express the transgene (Fig. 2A). In the
100bpGC6-Luc, line 12 medaka ¢sh, the luciferase gene was
expressed only in the intestine, although the OlGC6 gene tran-
Fig. 1. Summary of cis-regulatory element analysis of the OlGC6
gene using various OlGC6^luciferase fusion gene constructs. The
structures of the fusion genes were indicated at the left of the ¢gure.
White boxes show the 5P-leader sequence of OlGC6 gene and shaded
boxes denote the luciferase open reading frame. An untranscribed
5P-£anking region of the OlGC6 gene is indicated by a horizontal
line. Numbers at the top indicate nucleotide positions relative to the
transcription initiation site (+1). The luciferase fusion gene con-
structs were cotransfected with L-galactosidase control plasmid. On
the right side of the ¢gure, black boxes with a bar indicate the lucif-
erase activity in CACO-2 cells. Data represent the luciferase-to-L-ga-
lactosidase ratio and are expressed by fold activation relative to the
empty luciferase construct as 1. ‘n’ denotes the number of indepen-
dent transfections for each construct.
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script was detected mainly in the intestine and faintly in the
brain and liver, but not in the gill (Fig. 2B). The luciferase
gene was not expressed in any tissues of the non-transgenic
medaka ¢sh, although the OlGC6 gene was expressed in the
same tissues as in the transgenic medaka ¢sh (Fig. 2B). The
endogenous OlGC6 gene was expressed in the epithelial cells
in the basement of the intestinal folds (Fig. 2D). The medaka
¢sh is stomachless and the intestine is continuous with the
pharynx through a short esophagus [26,27]. Medaka ¢sh in-
testinal epithelium contains most of the cell types (enterocytes,
goblet cells, and enteroendocrine cells) observed in the small
intestine of other vertebrates, but lacks crypts and Paneth
cells. An intestinal stem cell has not been identi¢ed in the
teleost intestine, but it has been reported that the intestinal
epithelium undergoes continuous renewal and the di¡erenti-
ated enterocytes proliferate in the base of the intestinal fold
[26,27]. To localize the cells expressing the luciferase reporter
gene, in situ hybridization analysis was performed on sections
of the intestine of the 100bpGC6-Luc, lines 10 and 12 or wild
type as a control. A DIG-labeled luciferase antisense probe
hybridized to the epithelial cells from the basement to the
top of the intestinal folds (Fig. 2F). Hybridization with
the luciferase sense probe control showed no detectable
background staining (Fig. 2G). There was no detectable hy-
bridization of the luciferase antisense probe to the section
from wild-type medaka ¢sh (Fig. 2H). As a positive control,
the endogenous OlGC6 transcript was also localized to the
epithelial cells in the basement of the intestinal folds (Fig.
2I). These results suggest that the OlGC6 upstream region
between 398 and +50 is su⁄cient to drive intestinal expres-
sion in vivo.
3.4. Complex formation of the 5P-regulatory region of the
OlGC6 gene with CACO-2 or medaka intestinal nuclear
extracts
The ability of the ¢rst and second regions to form com-
plex(es) with nuclear proteins was determined by incubating
Fig. 2. Transgene expression in the embryos and in the adult intestine. A: Total RNA (2 Wg) extracted from F1 embryos of transgenic lines
was reverse-transcribed and PCR ampli¢ed using the luciferase or OlGC6 gene-speci¢c primers. B: Total RNA (500 ng) extracted from the
brain, gill, intestine, and liver of a non-transgenic medaka or a 100bpGC6-Luc, line 12 medaka ¢sh was reverse-transcribed and PCR ampli¢ed
using a speci¢c primer set for the luciferase, OlGC6 or OlCA1 gene, which was used as a positive control. C: Hematoxylin-eosin staining of
the section from the adult medaka ¢sh intestine. In situ hybridization analysis of the adult medaka ¢sh intestinal section from a non-transgenic
medaka ¢sh hybridized using a DIG-labeled OlGC6 antisense probe (D) and sense probe (E). In situ hybridization analysis of an adult medaka
¢sh intestinal section from a 100bpGC6-Luc line 12 medaka ¢sh (F), or a non-transgenic medaka ¢sh (H) hybridized using a DIG-labeled lucif-
erase antisense probe. G shows absence of staining in the 100bpGC6-Luc line 12 medaka ¢sh when hybridized with a DIG-labeled luciferase
sense probe. I shows a 100bpGC6-Luc line 12 medaka ¢sh hybridized with the OlGC6 antisense probe. ic, inner circular muscle layer; ol, outer
longitudinal muscle layer; lp, lamina propria; e, epithelium; scale bar, 50 Wm.
Fig. 3. Electrophoretic mobility shift assay with the E1 probe using
nuclear extracts prepared from adult medaka ¢sh intestinal cells
(A); and CACO-2 cells (B). Complex competition was achieved by
addition of unlabeled E1 (in 40-fold excess or 200-fold excess). Ar-
rowheads indicate speci¢c complexes.
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an oligonucleotide probe with nuclear extracts prepared from
CACO-2 cells or the medaka ¢sh intestine. Several complexes
were formed when the labeled ¢rst region was incubated with
the nuclear extracts prepared from CACO-2 cells, but no
complex was formed when incubated with the nuclear extracts
from the medaka ¢sh intestine (data not shown). However,
two complexes were formed when the E1 probe (containing
the second region) was incubated with the nuclear proteins
from CACO-2 cells, and a complex was formed when the
probe was incubated with the nuclear proteins from the med-
aka ¢sh intestine (Fig. 3). The complex-forming ability of E1
with the nuclear protein from the medaka ¢sh intestine was
abolished by addition of increasing amounts of unlabeled E1
(Fig. 3A). Although two complexes were formed using E1 and
the CACO-2 nuclear protein, complex formation (represented
by the upper band in Fig. 3B) was inhibited by addition of
increasing amounts of unlabeled E1, although the other com-
plex was formed even in the presence of 200-fold amounts of
unlabeled E1. Cross-linking and subsequent SDS^polyacryl-
amide gel electrophoresis (PAGE) experiments indicated that
the apparent molecular mass of the complex of E1 and bind-
ing protein from CACO-2 cells and the medaka ¢sh intestine
was 17 kDa (Fig. 4). However, the mobility of both complexes
in non-denaturing gels in the EMSA seems to be slightly dif-
ferent, probably due to the complex formation by E1 and the
same nuclear binding protein associated with additional di¡er-
ent protein factor or subunit.
3.5. Nucleotides required for protein binding
The nucleotides in E1 responsible for protein binding were
identi¢ed by EMSA, examining the competition of unlabeled
competitors for labeled wild-type E1 binding to CACO-2 cells
or the medaka ¢sh intestinal nuclear extracts (Fig. 5). In each
assay, competitors 5, 7, and 12 did not compete with labeled
wild-type E1, suggesting that the nucleotides AG in the sec-
ond region are important for binding to the nuclear protein.
However, since nucleotides are located at the 3P-end of the
second region we also introduced mutations into the further
downstream region (in competitors 13, 14, 15, 16, and 17) and
examined their competitive activity by the EMSA with
CACO-2 cells or medaka ¢sh intestinal nuclear extracts
Fig. 4. UV cross-linking analysis using nuclear extracts prepared
from CACO-2 cells and the adult medaka ¢sh intestinal cells. Com-
plex competition was achieved by addition of a 40-fold excess
amount of unlabeled E1.
Fig. 5. Competitive EMSA of labeled E1 and unlabeled mutated competitors. A: Competitors for the EMSA. The mutated nucleotides are indi-
cated by bold letters with underline. B: Medaka ¢sh intestinal nuclear extracts were combined with labeled E1 in the presence or absence of a
20-fold excess of the indicated unlabeled competitor. C: CACO-2 nuclear extracts were combined with labeled E1 in the presence or absence of
a 40-fold excess of the indicated unlabeled competitor.
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(Fig. 5). In each assay, competitors 13, 14, 15, and 16 did not
compete with labeled wild-type E1, indicating that the
AGACCTTTGC nucleotides are critical for binding to the
nuclear protein from CACO-2 cells and the medaka ¢sh in-
testine.
3.6. Speci¢c complex formation of E1 with a protein in the
intestinal nuclear extracts
Several complexes were formed when labeled E1 was incu-
bated with brain, testis, or liver nuclear extracts, and these
could be competed by excess unlabeled E1 (data not shown).
However, all of these complexes exhibited mobility patterns
di¡erent from that of the intestine-speci¢c complex (data not
shown).
4. Discussion
The 5P-£anking region of the OlGC6 gene contains several
putative consensus binding sequences for transcriptional fac-
tors such as GATA protein family members and Cdx2, all of
which are involved in the development of intestine [24,25]. In
order to understand the mechanisms of transcriptional regu-
lation of the OlGC6 gene, we analyzed the cis-regulatory re-
gion of the OlGC6 gene by transfecting the luciferase fusion
gene into mammalian cells and by generating transgenic lines
of the medaka ¢sh O. latipes. From in vitro transient trans-
fection assays, we identi¢ed three regions in£uencing tran-
scription of the OlGC6 gene by a stepwise deletion of the
5P-£anking region. The ¢rst region was detected between
3299 and 3201, a region that is important for transcription
of the OlGC6 gene in CACO-2 cells. However, the labeled ¢rst
region did not form a complex with nuclear proteins from
medaka ¢sh intestinal cells in the EMSA. The third region
between 347 and 318 contained a putative TATA box, and
deletion of the region resulted in a large decrease in luciferase
activity, suggesting that the OlGC6 gene is a TATA-depen-
dent gene in vitro. The second region, between 398 and 389
(GCACACACAG), was important for OlGC6 transcription in
the CACO-2 cells. The E1 probe containing the second region
formed speci¢c complexes with a nuclear protein from
CACO-2 cells and a speci¢c complex with a medaka ¢sh in-
testinal nuclear protein (Fig. 3). Furthermore, the complex
formed by E1 and the medaka intestinal nuclear protein was
intestine speci¢c, suggesting that the second region is impor-
tant for the transcription of the OlGC6 gene in the medaka
¢sh intestine. This may be supported by the results obtained
from in situ hybridization experiments using 100bpGC6-Luc
transgenic medaka ¢sh lines, demonstrating that the luciferase
gene in the medaka ¢sh genome was expressed in the adult
transgenic medaka ¢sh intestine, although the expression pat-
tern was slightly di¡erent from the endogenous OlGC6 tran-
script; i.e. the luciferase gene expression was expanded to the
top of the intestinal folds (Fig. 2F). RT-PCR analysis also
demonstrated that the transgene was detected in the
2kbpGC6-Luc and 100bpGC6-Luc transgenic lines, but not
in the 50bpGC6-Luc and 20bpGC6-Luc transgenic lines
(Fig. 2A). As shown in Fig. 2B, the expression of the lucifer-
ase gene was detected only in the intestine by RT-PCR when
the 100bpGC6-Luc, line 12 transgenic medaka ¢sh was exam-
ined. From these results, we conclude that the 5P-£anking
region of the OlGC6 gene between 398 and +50 is su⁄cient
to drive the intestine-speci¢c gene expression. On the other
hand, our results demonstrating that a nuclear protein from
CACO-2 cells or the medaka intestinal cells recognizes the
same sequence (AGACCTTTGC) for binding (Fig. 5), and
that introduction of mutation into the sequence (the nucleo-
tides AG) resulted in reduction of the promoter activity (Fig.
1), suggest that the binding protein(s) contribute to the tran-
scription of the OlGC6 gene. Considering that a nuclear pro-
tein both from the mammalian and medaka ¢sh intestinal cells
binds to the same region, the sequence is clearly important to
intestine-speci¢c transcription of the intestinal membrane GC
and has been conserved during the evolution of vertebrates. A
database search revealed that there is no highly conserved
consensus binding sequence in the second region for a known
transcriptional factor, suggesting that the second region is a
novel regulatory element.
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